Abstract 3994: Differences in the mutational landscape across race and sex highlight distinct TP53-associated risk in multiple myelomaChidiebube Ugwu, Amin Turki, Nneoma Ubah et al.|Cancer Research|2026Cited by 0
Timing of Tyrosine Kinase Inhibitor Switching in Chronic Myeloid Leukemia: A Comparative Analysis of Early Versus Late StrategiesChidiebube J. Ugwu, Alankrita Taneja, Nneoma Ubah et al.|Clinical Lymphoma Myeloma & Leukemia|2026Cited by 0